EBIT Margin: Earnings before interest and taxes as a portion of total revenues. Calculated as: EBIT / Total Revenues
Indivior Pharmaceuticals Inc. (INDV) had EBIT Margin of 22.41% for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$357.00M |
|
$103.00M |
|
$67.00M |
|
$290.00M |
|
$277.00M |
|
$80.00M |
|
-- |
|
$81.00M |
|
$81.00M |
|
$103.00M |
|
$103.00M |
|
$103.00M |
|
$102.00M |
|
$80.00M |
|
$85.00M |
|
125.00M |
|
128.00M |
|
$0.81 |
|
$0.79 |
|
| Balance Sheet Financials | |
$652.00M |
|
$144.00M |
|
$550.00M |
|
$1.20B |
|
$914.00M |
|
$290.00M |
|
$385.00M |
|
$1.30B |
|
$-99.00M |
|
$-101.00M |
|
$-98.00M |
|
125.00M |
|
| Cash Flow Statement Financials | |
$-27.00M |
|
$-66.00M |
|
$-30.00M |
|
$319.00M |
|
$195.00M |
|
$-124.00M |
|
$26.00M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.71 |
|
-- |
|
-- |
|
1.51 |
|
-3.26 |
|
82.07% |
|
22.41% |
|
|
EBIT Margin |
22.41% |
-- |
|
22.69% |
|
28.85% |
|
$-93.00M |
|
-- |
|
-- |
|
-- |
|
0.30 |
|
0.44 |
|
1.40 |
|
64.29 |
|
-104.04% |
|
-101.98% |
|
8.58% |
|
53.65% |
|
$-0.78 |
|
$-0.73 |
|
$-0.21 |
|